VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 154 filers reported holding VERASTEM INC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $241 | -0.4% | 579,400 | -3.6% | 0.00% | – |
| Q4 2022 | $242 | -100.0% | 600,989 | -21.4% | 0.00% | -100.0% |
| Q3 2022 | $650,000 | +62.5% | 764,375 | +121.6% | 0.00% | – |
| Q2 2022 | $400,000 | -83.2% | 344,900 | -79.5% | 0.00% | -100.0% |
| Q1 2022 | $2,375,000 | +99.6% | 1,684,106 | +190.2% | 0.00% | +200.0% |
| Q4 2021 | $1,190,000 | -43.4% | 580,300 | -15.1% | 0.00% | -66.7% |
| Q3 2021 | $2,104,000 | +6.6% | 683,200 | +40.8% | 0.00% | +50.0% |
| Q2 2021 | $1,974,000 | -24.0% | 485,100 | -53.8% | 0.00% | -33.3% |
| Q1 2021 | $2,596,000 | +9514.8% | 1,051,119 | +8309.0% | 0.00% | – |
| Q4 2020 | $27,000 | -78.6% | 12,500 | -86.8% | 0.00% | – |
| Q4 2019 | $126,000 | -91.5% | 94,400 | -90.4% | 0.00% | -100.0% |
| Q2 2019 | $1,479,000 | -54.1% | 979,200 | -10.1% | 0.00% | -66.7% |
| Q1 2019 | $3,224,000 | +28.0% | 1,089,200 | +45.3% | 0.00% | 0.0% |
| Q4 2018 | $2,519,000 | -77.9% | 749,700 | -69.1% | 0.00% | -50.0% |
| Q2 2018 | $11,378,000 | +181.6% | 2,422,400 | +78.6% | 0.01% | +50.0% |
| Q1 2018 | $4,041,000 | -22.2% | 1,356,000 | -19.8% | 0.00% | -33.3% |
| Q4 2017 | $5,192,000 | -47.4% | 1,691,300 | -19.4% | 0.01% | -50.0% |
| Q3 2017 | $9,865,000 | +138.2% | 2,098,900 | +10.5% | 0.01% | +140.0% |
| Q2 2017 | $4,141,000 | +63.1% | 1,899,600 | +54.9% | 0.01% | +25.0% |
| Q1 2017 | $2,539,000 | +121.7% | 1,226,600 | +20.0% | 0.00% | +100.0% |
| Q4 2016 | $1,145,000 | -4.3% | 1,022,200 | +13.6% | 0.00% | 0.0% |
| Q3 2016 | $1,196,000 | +45.0% | 899,600 | +41.7% | 0.00% | 0.0% |
| Q2 2016 | $825,000 | +14.1% | 634,900 | +38.8% | 0.00% | +100.0% |
| Q1 2016 | $723,000 | +357.6% | 457,438 | +438.5% | 0.00% | – |
| Q4 2015 | $158,000 | -85.9% | 84,945 | -42.8% | 0.00% | -100.0% |
| Q2 2015 | $1,119,000 | +2.8% | 148,444 | +38.6% | 0.00% | +50.0% |
| Q1 2015 | $1,089,000 | -41.8% | 107,100 | -47.7% | 0.00% | -60.0% |
| Q4 2014 | $1,872,000 | +231.3% | 204,787 | +208.9% | 0.01% | +150.0% |
| Q3 2014 | $565,000 | -18.5% | 66,300 | +19.0% | 0.00% | 0.0% |
| Q3 2013 | $693,000 | +184.0% | 55,700 | +216.5% | 0.00% | +100.0% |
| Q2 2013 | $244,000 | – | 17,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |